期刊文献+

新生儿溶血病换血术前后凝血功能的变化分析 被引量:4

Analysis on the changes of coagulation function of the newborn's haemolytic disease before and after exchange transfusion
暂未订购
导出
摘要 目的探讨新生儿溶血病换血术前后凝血功能的变化。方法对52例重度溶血病新生儿换血术前后的凝血功能、血小板进行测定分析,以同期出生的正常新生儿为对照组。结果换血术后的患儿活化的部分凝血活酶时间(APTT)明显延长,纤维蛋白原(FIB)含量增高,血小板计数(PLT)数量减低,差异有统计学意义(P<0.05),血浆凝血酶原时间(PT)有轻度延长,但差异无统计学意义(P>0.05)。结论新生儿溶血病换血术前后应进行凝血功能的检测,并及时处理,以防止发生大出血及DIC。 Objective To investigate the coagulation function changes of the newborn’s haemolytic disease before and after exchange transfusion.Methods Check and analyze the coagulation function and blood platelet of 52 serious newborn haemolytic disease cases before and after exchange transfusion,and compare with the same term normal newborn.Results Activated partial thromboplastin time(APPT) was prolonged obviously after exchange transfusion,fibrinogen(FIB) content increased,and platelet(PLT) quantity was reduced.The difference has the statistical significance,(P0.05).Conclusion It is required to check the coagulation function of the newborn haemolytic disease before and after exchange transfusion,and deal with it in time to avoid massive haemorrhage and DIC.
出处 《临床军医杂志》 CAS 2012年第1期165-166,共2页 Clinical Journal of Medical Officers
关键词 新生儿溶血病 换血术 凝血功能 血小板计数 newborn haemolytic disease exchange transfusion coagulation function blood platelet counts
  • 相关文献

参考文献6

二级参考文献28

  • 1王欲琦,李俊玲,史胜平,宋兰平,葛慧,李冬,丁玲俊.新生儿不同胎龄、日龄和黄疸对凝血四项水平影响[J].小儿急救医学,2005,12(6):485-487. 被引量:11
  • 2Pugh M.DIC screening in the newborn[J].Neonatal Netw,1997,16(7):57-60.
  • 3Daimon T,Nakanno M.Immunohistochemical localization of thrombomodulin in the stratified epithelium of the rat is restricted to the keratinizing epidermis[J].Histochem Cell,Biol[J].1999,112(6):437-442.
  • 4Wada H,Wakita Y,Nakase T,et al.Increased plasmasoluble fibrin monomer levels in patients with disseminated intravascular coagulation[J].Am J Hematol,1996,51(4):255-260.
  • 5Wada H,Sakuragawa N,Shiku H.Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemia patients[J].Semin Thromb Hemost,1998,24(3):293-297.
  • 6Wada H,Mori Y,Shimura M,et al.Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purura patient s with severe vascular endothelial cell injuries[J].Am J Hemtol,1998,58(3):189-194.
  • 7Watanabe R,Wada H,Miura Y,et al.Plasma levels of total plasminogen activator inhibitor-I(PAI-I)and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura[J].Clin Appl Thromb Hemost,2001,7(3):229-233.
  • 8Bos R,Laterveer-Vreeswijk GH,Lockwood D,et al.A new enzyme immunoassay for soluble fibrin in plasma,with a high discriminating power for thrombotic disorders[J].Thromb Haemost,1999,81(1):54-59.
  • 9Okajima K,Uchiba M,Murakami K,et al.Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation[J].Am J Hematol,1996,51(3):186-191.
  • 10Chan JC.Gene targeting in hemostasis.Tissue factor pathway inhibitor[J].Front Biosci,2001,6:D216-221.

共引文献342

同被引文献26

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部